Edition:
United Kingdom

China Biologic Reports Financial Results For The Fourth Quarter And Fiscal Year 2018


Wednesday, 6 Mar 2019 

March 6 (Reuters) - China Biologic Products Holdings Inc ::CHINA BIOLOGIC REPORTS FINANCIAL RESULTS FOR THE FOURTH QUARTER AND FISCAL YEAR 2018.Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.76.Q4 EARNINGS PER SHARE $0.87.BOARD OF DIRECTORS EXTENDS PREVIOUSLY APPROVED SHARE REPURCHASE PROGRAM.QTRLY TOTAL SALES $114.9 MILLION VERSUS $90.1 MILLION.CHINA BIOLOGIC PRODUCTS HOLDINGS - BOARD APPROVED EXTENSION TO PREVIOUSLY AUTHORIZED $100 MILLION SHARE REPURCHASE PROGRAM FOR ANOTHER 6 MONTHS UNTIL OCT 31, 2019.CHINA BIOLOGIC PRODUCTS HOLDINGS SEES 2019 NON-GAAP ADJUSTED INCOME FROM OPERATING AND NON-GAAP ADJUSTED NET INCOME TO INCREASE BY 4%-6% IN RMB TERMS OVER FY 2018 RESULTS.CHINA BIOLOGIC PRODUCTS HOLDINGS - TOTAL SALES, NON-GAAP ADJUSTED NET INCOME IN USD TERMS IN 2019 COULD BE AFFECTED BY FOREIGN CURRENCY TRANSLATION IMPACT.FY2019 EARNINGS PER SHARE VIEW $4.38, REVENUE VIEW $479.9 MILLION -- REFINITIV IBES DATA."ANTICIPATE THAT POLICY HEADWINDS WILL CONTINUE TO BE CHALLENGING IN SHORT TERM". 

Company Quote

93.0
-0.64 -0.68%
19 Jul 2019